Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
14:20:05 EDT Wed 16 Jul 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:AIFF - FIREFLY NEUROSCIENCE INC - https://investors.fireflyneuro.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
AIFF - Q0.12.92·2.940.12.93+0.186.5531.31,3861,9232.75  2.94  2.7517.20  1.8614:02:59Jul 1415 min RT 2¢

Recent Trades - Last 10 of 1923
Time ETExPriceChangeVolume
14:03:06Q2.940.193
14:02:59Q2.930.18100
14:02:30Q2.93990.18999
14:01:59Q2.92020.1702762
14:01:53Q2.940.191
14:01:34Q2.930.18200
14:01:34Q2.930.18100
14:01:34Q2.920.17100
14:01:34Q2.92010.1701100
14:01:34Q2.9210.171100

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-07-14 07:45U:AIFFNews ReleaseFirefly Inks Latest Commercial Agreement for Use of its FDA-Cleared BNA(TM) Platform in Groundbreaking Precision Neuroscience Research
2025-06-23 08:05U:AIFFNews ReleaseFirefly Neuroscience to be Added to the Russell Microcap(TM) Index
2025-06-20 07:45U:AIFFNews ReleaseFirefly Neuroscience Researchers Uncover Powerful New Way of Objectively Measuring SCD, MCI, and Dementia in Alzheimer's Patients
2025-05-05 21:00U:AIFFNews ReleaseCorrection From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.
2025-05-05 07:45U:AIFFNews ReleaseFirefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.
2025-03-06 07:31U:AIFFNews ReleaseHemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
2025-02-21 08:00U:AIFFNews ReleaseFirefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million
2025-02-11 07:45U:AIFFNews ReleaseFirefly Neuroscience Accepted into NVIDIA Connect Program
2025-02-07 07:30U:AIFFNews ReleaseFirefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum Electronics
2025-01-24 09:00U:AIFFNews ReleaseFirefly Neuroscience Announces Publications Demonstrating the Utility of Advanced EEG Analytics in Drug Development and Neuropsychiatric Care
2025-01-14 07:45U:AIFFNews ReleaseFirefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA(TM) Platform
2024-12-31 09:00U:AIFFNews ReleaseFirefly Neuroscience Closes on Financing of up to $12.4 Million
2024-12-04 09:00U:AIFFNews ReleaseFirefly Neuroscience Appoints Current Board Member, Greg Lipschitz, as Executive Chairman
2024-11-14 17:30U:AIFFNews ReleaseFirefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update
2024-11-06 09:00U:AIFFNews ReleaseFirefly Neuroscience to Participate in the 8th Annual Florida Capital Event
2024-10-25 16:10U:AIFFNews ReleaseFirefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2024-10-21 08:30U:AIFFNews ReleaseBright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data
2024-10-16 09:20U:AIFFNews ReleaseFirefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA(TM) Technology
2024-10-15 09:00U:AIFFNews ReleaseFirefly Neuroscience Announces Use of Its Brain Network Analytics Platform in Phase 1 Study of SP-624, the First Potential Treatment Designed for Women with Major Depressive Disorder
2024-10-11 09:00U:AIFFNews ReleaseFirefly Neuroscience to Participate in Upcoming October Investor Conferences